SHOX2 and neoplasm: The expression of SHOX2 was significantly higher in tumor samples at Stage I-II than that in normal samples, but there was a negative correlation between SHOX2 expression and its promoter methylation level in tumor samples at Stage I (Spearman correlation, P < 0.05) (Figure 4C).